{
  "docId": "019de06f-52ef-7226-b4e8-f3f08eb88a26",
  "docSlug": "7c032e01619eda769cbeaf2bcfe382bc",
  "documentTitle": "Pershing Square | Activist Presentation Deck | 110 slides",
  "authorId": "pershing-square",
  "authorName": "Pershing Square Capital Management",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2014-04-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 1,
  "pageCount": 110,
  "prevPage": null,
  "nextPage": 2,
  "slideType": "cover",
  "function": "front_matter",
  "density": "sparse",
  "nDataPoints": 0,
  "notes": "Includes SEC filing disclaimer in the top right corner.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": "https://imgproxy.kitesheet.com/FLPMbLajYmBuGd7tdSZXNmWDwRLUHmGrLhGZ0NHB_EM/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83YzAzMmUwMTYxOWVkYTc2OWNiZWFmMmJjZmUzODJiYy9wMDAxLmpwZw",
  "slideHref": "/slides/019de06f-52ef-7226-b4e8-f3f08eb88a26/1",
  "deckHref": "/decks/019de06f-52ef-7226-b4e8-f3f08eb88a26",
  "deckJsonHref": "/decks/019de06f-52ef-7226-b4e8-f3f08eb88a26.json",
  "deckAnchorHref": "/decks/019de06f-52ef-7226-b4e8-f3f08eb88a26#slide-1",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.35,
        "x": 0.6,
        "y": 0.05
      },
      "kind": "disclaimer",
      "text": "Filing under Rule 425 under the Securities Act of 1933 and deemed filed under Rule 14a-12 of the Securities Exchange Act of 1934. Filed by: Pershing Square Capital Management, L.P. Subject Company: Valeant Pharmaceuticals International, Inc. SEC File No. of Valeant Pharmaceuticals International, Inc.: 001-14956",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "258b31b5-a17d-4260-b4c9-138cdd466755",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.6,
        "x": 0.05,
        "y": 0.82
      },
      "kind": "image",
      "text": "Pershing Square Capital Management, L.P.",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "41731556-cfc5-4625-b288-83ea9bd465ca",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.3,
        "x": 0.35,
        "y": 0.27
      },
      "kind": "title",
      "text": "The Outsider",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "33fe49d1-7b2d-420a-b37c-e61512f023b0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.7,
        "x": 0.15,
        "y": 0.41
      },
      "kind": "title",
      "text": "Perspectives from Allergan's Largest Shareholder",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4606ba23-f3e9-4586-98a0-83ad75cc1ab1",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": "https://imgproxy.kitesheet.com/qhsD4DgWkwdMmV00PhD8bIfNoodIG6u9aEixuyr9nAw/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83YzAzMmUwMTYxOWVkYTc2OWNiZWFmMmJjZmUzODJiYy9wMDAxLnBuZw",
  "thumbSrc": "https://imgproxy.kitesheet.com/zUOLH_mcll3vih0yvbqj2JDmzDFZ-WztlUN-Z1nFVLA/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83YzAzMmUwMTYxOWVkYTc2OWNiZWFmMmJjZmUzODJiYy9wMDAxLmpwZw",
  "thumbSrcAlt": "https://imgproxy.kitesheet.com/xT3t0H3b8YOI_zPeRM1zb9xBpO_ByLQrNPkURTp92qI/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83YzAzMmUwMTYxOWVkYTc2OWNiZWFmMmJjZmUzODJiYy9wMDAxLnBuZw"
}